Phibro Animal Health: Zoetis Integration Poised to Restore Margins and Drive Cash Flow
Phibro (PAHC) looks set to turn a recent acquisition into durable margin and cash-flow upside. The Zoetis medicated feed-additive portfolio and management continuity following a CEO transition create a clear operational catalyst. At a $1.53B market cap and EV/EBITDA of 8.95, the stock is reasonably valued for a company with improving revenue growth…